Follow us on social media for our latest updates.
A team of scientists led by Bart De Strooper (VIB-KU Leuven) set out to identify small regulatory molecules called miRNAs that are involved in the development of Alzheimer’s disease. They found a handful of candidates that were upregulated in different animal models and in patients, but their link to the disease turns out to be more puzzling than anticipated.
In a recent study in Molecular Neurodegeneration, researchers from VIB-KU Leuven led by prof. Philip Van Damme, reveal neuroprotective effects of progranulin against TDP-43 accumulation and neurodegeneration. The findings suggest that progranulin treatment may not only be of interest to certain patients with frontotemporal dementia, but also to patients with ALS.
CBD @ Biotechdag Check our instagram for pictures!
Brain Art exhibition at Liege Guillemins featuring works by several CBD scientists!
Each of our immune systems acts a little bit differently. Environmental factors have an impact, but so do our genes. A team of researchers in Leuven went looking for links between more than 10 million genetic variations and more than 50 immunological traits. Their findings help to explain why some people have a higher risk for immune diseases than others.
2018 edition of our yearly PhD Class and Symposium, organized together with NERF.
Researchers at VIB and KU Leuven have uncovered a new molecular interaction that governs the formation of specific functional connections between two types of neurons. It gives an important clue as to how unique interactions give shape to precisely organized neuronal networks in the brain.
VIB team maps each individual fly brain cell throughout the aging process. Stein Aerts (VIB-KU Leuven Center for Brain & Disease Research) and his team have accomplished a world first: a gene expression map of every cell within the brain of an aging fly. While fly brains are comparatively simple, consisting of only 100,000 different cells, they are still complex networks that aptly serve as models for the human brain. Thus, the atlas is a key step toward a better understanding of human disease development.
Verge Genomics, a drug discovery company utilizing machine learning to develop new therapeutics, launched an initiative to study gene expression in the brains of Parkinson’s patients at single-cell resolution, generating the first dataset of its kind in the field. To do this, the company joins forces with VIB and the University of California San Diego.
In 2020, we'll move into a brand new facility!